Board of Directors



Mr. Midler serves as Managing Member at Savitr Capital, LLC which has its primary focus in health care venture investments. Mr. Midler founded the firm in 2008. Previously, Mr. Midler served as Chief Executive Officer and Chief Investment Officer at Standard Pacific Capital. From 1986 to 1993, he worked as a Portfolio Manager at Fidelity Investments. Mr. Midler holds an MBA from Harvard Business School. He earned MA and BA degrees in political science from Stanford University.





Mr. Frank started his investment career in 1979 as an analyst with Fidelity Management and Research (Fidelity Investments). In 1981, he became an assistant to Peter Lynch on the Fidelity Magellan Fund and in 1982, he formally launched his own fund, Fidelity Special Situations/Strategic Opportunities Fund, which grew to over $800 million. For a decade, Mr. Frank was a Managing Director at Cerberus Capital Management, responsible for healthcare related investments in both the public and private markets, from start-ups to established businesses in need of growth capital. In this role, he served as lead investor, co-investor, and in various roles on the Board of Directors of the respective investments. The areas of focus encompassed diagnostics, specialty pharmaceuticals and medical devices.



Mr. Cua has more than 30 years of healthcare leadership experience, ranging from large Fortune 500 companies to startups focused on solutions for hospitals and health plans. Mr. Cua’s industry experience began with C.R. Bard and has included executive positions with CorSolutions, Matria Healthcare, Aetna and Alere. He currently serves as President of HSG Partners. In addition to serving on the Glytec Board of Directors, he also serves on the Board of Directors of several other successful, high-growth healthcare technology companies, including BioIQ (based in Santa Barbara, California) and GozioHealth (based in Atlanta, Georgia).



Deborah Dean is a highly respected technology executive with more than 25 years’ experience in the healthcare industry and extensive C-level expertise in operations, technology, data integration, analytics, applications development, informatics and technical infrastructure. She currently serves as Chief Analytics and Technology Officer at BioIQ, a healthcare engagement and gap closure company that is redefining the way payers, employers and consumers navigate and connect with the U.S. healthcare system. Prior to BioIQ, Deborah served as Executive Vice President at MiMedx, President and Chief Operating Officer at HolaDoctor, Executive Vice President and Chief Technology officer at Matria Healthcare, and Senior Vice President of Research at Quovadx, Inc. (now Lawson software). In 2008, she received the prestigious CIO of the Year Award from the Georgia CIO Leadership Association. Deborah holds a bachelor’s degree in health services administration from Arkansas State University.



Ed Furlong serves as Glytec’s President & CEO. His experience in operations and financial management spans more than 30 years. Prior to joining Glytec, Ed served as Chief Operating Officer and Chief Financial Officer at Kyruus, a leader in provider search and scheduling solutions for hospitals and health systems, where he was instrumental in shaping the business model, building the organization and increasing revenues elevenfold. 
Ed previously served in a similar capacity at Exa Corporation, maker of engineering simulation and visualization software, where he directed the company’s IPO, raised private equity and mezzanine debt financing, and achieved consistent growth and profitability. Earlier in his career, he served as a senior executive in the investment services industry for both Fidelity Strategic Investments and UAM Investment Services, where he spearheaded a wide range of start-ups and turnarounds, and participated on several corporate boards. Ed holds a bachelor of science in economics from The Wharton School at the University of Pennsylvania and a master of business administration from Harvard Business School.